Covestor’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Other funds holding XERS
Covestor's XERS Position: Q3 2026 in Review
Covestor sold out of Xeris Biopharma Holdings (XERS) in Q3 2026, closing a stake of 138 shares — an estimated $1K sold.
Covestor first reported a position in XERS in Q1 2025 and held it in 6 quarters. The position peaked at $3K in Q3 2025. 249 funds tracked by Wall St. Rank hold XERS as of Q3 2026.
- Covestor reported no remaining Xeris Biopharma Holdings position as of Q3 2026 after selling out during the quarter.
- Covestor sold 138 Xeris Biopharma Holdings shares in Q3 2026, an estimated $1K.
- Covestor first reported a position in Xeris Biopharma Holdings in Q1 2025 and held it in 6 quarters.
- Covestor's Xeris Biopharma Holdings position peaked at $3K in Q3 2025.
- 249 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.